Inconsistent and Inaccurate Cancer Clinical Trial Reporting of Venous and Arterial Thrombotic Events: An Urgent Call to Action
D
David C. Calverley
(Section of Hematology/Oncology, Division of Hospital and Specialty Medicine, Portland VA Medical Center, Portland, OR)
A
Avi Leader
(1Memorial Sloan Kettering Cancer Center, Hematology Service, New York, United States)
M
May Anne Cheong
(Department of Haematology, Singapore General Hospital, Singapore)
K
Kristen M. Sanfilippo
(Washington University School of Medicine, St. Louis)
G
Ginny Mason
(Breast and Digital Engagement Committees, SWOG Cancer Research Network, Portland, OR)
G
Gary H. Lyman
(Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA)
N
Nicole M. Kuderer
(Advanced Cancer Research Group, Kirkland, WA)
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 43, Issue 26
Published
September 10, 2025
Pages
2851-2855
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (7)
D
David C. Calverley
Section of Hematology/Oncology, Division of Hospital and Specialty Medicine, Portland VA Medical Center, Portland, OR
A
Avi Leader
1Memorial Sloan Kettering Cancer Center, Hematology Service, New York, United States
M
May Anne Cheong
Department of Haematology, Singapore General Hospital, Singapore
K
Kristen M. Sanfilippo
Washington University School of Medicine, St. Louis
G
Ginny Mason
Breast and Digital Engagement Committees, SWOG Cancer Research Network, Portland, OR
G
Gary H. Lyman
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA
N
Nicole M. Kuderer
Advanced Cancer Research Group, Kirkland, WA
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001